Daewoong first-quarter sales increase 12%

Daewoong Pharm said its first-quarter (April-June) sales rose a better-than-expected 12.4 percent from a year ago, driven by robust sales of flagship products such as Ursa and Almetec (almesartan medoxomil), analysts say.

Sales rose 12.4 percent to 90.2 billion won in the April-June period.

First-quarter operating profit also gained 55.4 percent from a year earlier to 15.2 billion won, Da...